221 In the index

Sermorelin + GHRP-2 SER/GHRP

A combination pairing sermorelin with GHRP-2, another growth-hormone-boosting peptide, meant to produce a bigger combined hormone release than either alone. This claimed benefit is based on how each works separately, not on any dedicated human study of the combination.

Also known as Blend

Effects Build muscle

Routes Subcutaneous

Legal status Research chemical

WADA Banned at all times

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Sermorelin 200-300 mcg + GHRP-2 100-200 mcg, combined

Reported range Varies by vendor/clinic protocol

Route Subcutaneous injection

Frequency Once or twice daily, typically before bed

Duration 3-6 month course (unregulated/clinic use)

A common 'GH-boosting' combination used at some anti-aging clinics and sold via research-chemical vendors; the combination itself has not been formally studied in controlled human trials.

Where this comes from Clinic/compounding-pharmacy and user-reported literature

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.